| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Oct 3, 2025 | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | Sell | 46.3 | -1,871 | -3.27% | ✗ | $32.5K |
| Jul 2, 2025 | Jul 3, 2025 | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | Sell | 46.3 | -2,503 | -4.20% | ✗ | $24.9K |
| Jan 3, 2025 | Jan 7, 2025 | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | Sell | 46.3 | -1,372 | -2.92% | ✗ | $16.7K |
| Oct 2, 2024 | Oct 4, 2024 | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | Sell | 46.3 | -2,012 | -4.10% | ✗ | $38.2K |